LGBTQ

Managing Acne Among Individuals Receiving Masculinizing Hormone Therapy (MHT)
MHT in Transgender Men
by Dustin Marks, BS - Matthew Mansh, MD on
Masculinizing hormone therapy (MHT) represents a common therapeutic intervention for transgender men (female-to-male) and other gender diverse individuals. MHT typically involves the use of one of several forms of parenteral testosterone (e.g. gel, patch, intramuscular, pellet).1 The goal of MHT is to help develop masculine secondary sex characteristics and/or suppress feminine characteristics in …
Journal Review Series: January-March 2019
Dermatology Journals
by ANNA H. CHACON, MD on
Next Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of January, February, and March of 2019. It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the …
Dr. Landriscina on Caring for LGBTQ+ Patients
LGBTQ
by ANNA H. CHACON, MD on
At the 17th ODAC Dermatology, Aesthetic and Surgical Conference held January 17-20, 2020 in Orlando, FL, Dr. Angelo Landriscina led a session on developing new approaches to caring for LGBTQ+ patients. Next Steps correspondent Dr. Anna Chacon reports back on highlights and pearls from the session which covered the following: Why this topic? Updating Our Understanding of SGM Pa …
Spotlight on OUTMed
LGBTQ+
by NEXT STEPS IN DERM TEAM on
In an effort to shed light on the importance of incorporating LGBTQ+ health in medical curriculums and understanding the role that dermatologists play in caring for LGBTQ+ patients, Next Steps in Derm reached out to Dr. Kara Sternhell-Blackwell, Assistant Professor of Dermatology and Director of LGBTQ Initiatives in Medicine at Washington University School of Medicine. Dr. Blackwell’s active inv …
PrEP: What Dermatologists Need to Know
PrEp Pre-Exposure Prophylaxis
by Angelo Landriscina, MD on
As dermatologists, we are well-versed in the sequelae of HIV infection.  Thankfully, HIV is now manageable for most patients due to the availability of highly active antiretroviral therapy (HAART).  Pre-exposure prophylaxis (PrEP) is an HIV prevention strategy in which some of the same medications used in HAART regimens are taken by patients who are at risk for HIV infection in order to prevent …